|
Potent Narcotic 'Lollipop' Becomes Best Seller_WSJ |
|
|
|
|
Saturday, 04 November 2006 |
|
Off-label prescribing of drugs for unapproved uses puts consumers at high risk of harm--but it is the single most lucrative marketing strategy. |
|
Read more...
|
|
|
Separating the Facts from the Propaganda_Latest Findings of Depression Study |
|
|
|
|
Thursday, 02 November 2006 |
|
Today's news report circulated by the media about the negative findings of a much touted, but uncontrolled observational study of depression (STAR*D) promotes the business interests of SSRI antidepressant drug manufacturers. |
|
Read more...
|
|
|
Newsweek Interviews FDA Chief of CDER about Needed Changes |
|
|
|
|
Saturday, 14 October 2006 |
|
FDA's Dr. Steven Galson, like his predecessor who now occupies a position in the Commissioner's office, demonstrates disconnectedness from reality, much like Nero who fiddled while Rome burned... |
|
Read more...
|
|
|
Science Refutes Claims of Drug Benefit: Antipsychotics Found Harmful_NEJM |
|
|
|
|
Thursday, 12 October 2006 |
"The drugs most commonly used to soothe agitation and aggression in people with Alzheimer's disease are no more effective than placebos for most patients, and put them at risk of serious side effects, including confusion, sleepiness and Parkinson's disease-like symptoms, researchers are reporting
today." |
|
Read more...
|
|
|
The FDA and Drug Safety: A Proposal for Sweeping Changes |
|
|
|
|
Wednesday, 11 October 2006 |
|
A Special Article By Curt D. Furberg, MD, PhD; Arthur A. Levin, MPH; Peter A. Gross, MD; Robyn S. Shapiro, JD; Brian L. Strom, MD, MPH |
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 28 - 36 of 88 |
Safety Issues